pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-04×clear all
type
  • 8k filing3,350
  • grant1,080
  • device adverse event1,000
  • earnings579
  • approval519
  • device 510k408
device pma
236
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 16, 2026

    50
    ›Mar 16, 2026approval153d agoNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalrimegepant sulfate ODT

    Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →rimegepant sulfate ODT →fda approvals ↗
    ›Mar 16, 2026approval153d agoFLUTICASONE PROPIONATE — FDA approvalFluticasone Propionate Glenmark

    Sponsor: GLENMARK PHARMS LTD. Form: SPRAY, METERED. Route: NASAL

    full page →Fluticasone Propionate Glenmark →fda approvals ↗
    ›Mar 16, 2026approval153d agoDESOXIMETASONE — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 16, 2026approval153d agoACAMPROSATE CALCIUM — FDA approvalacamprosate calcium DR

    Sponsor: APPCO. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →acamprosate calcium DR →fda approvals ↗
    ›Mar 16, 2026approval153d agoDESOXIMETASONE — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 16, 2026approval153d agoERIBULIN MESYLATE — FDA approvalEisai Co Ltd

    Sponsor: XGEN PHARMS. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 16, 2026approval153d agoELTROMBOPAG — FDA approval

    Sponsor: DR REDDYS. Form: TABLET

    full page →fda approvals ↗
    ›Mar 16, 2026approval153d agoLAMOTRIGINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 16, 2026approval153d agoLAMOTRIGINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 16, 2026device 510k153d agoOrthocon, Inc. — Montage Flowable Settable, Resorbable Bone Paste (Burr Hole Cover) (510k cleared)

    Product code: GXR. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoShanghai Achieva Medical Suzhou Co., Ltd. — DCwire Micro-guidewire (510k cleared)

    Product code: MOF. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoLifemotion Medical Technology Co., Ltd. — Lifemotion Disposable Membrane Oxygenator (510k cleared)NewBay Medical Technology Co Ltd

    Product code: DTZ. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoIzenimplant Co., Ltd. — ZENEX Implant System_Short (R-System) (510k cleared)

    Product code: DZE. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoMedartis AG — APTUS Shoulder Proximal Humerus System, PentaLock 3.5 (510k cleared)

    Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoCarboFix Orthopedics , Ltd. — CarboClear® Posterior Cervical Screw System; CarboClear® Hybrid Posterior Cervical Screw System (510k cleared)

    Product code: NKG. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoMedtronic Navigation, Inc. — Stealth AXiS™ ENT clinical application (510k cleared)

    Product code: PGW. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoStryker Instruments — SurgiCount+ System (510k cleared)

    Product code: PBZ. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoSonio — Sonio Detect (v3) (510k cleared)

    Product code: IYN. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoHealgen Scientific,, LLC — Healgen® Accurate Oral Fluid Drug Test (510k cleared)

    Product code: DJC. Advisory committee: Clinical Toxicology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoPerfuze, Ltd. — Millipede System (510k cleared)

    Product code: NRY. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoBAAT Medical Products B.V. — SINEFIX (510k cleared)

    Product code: MBI. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoVoronoi Health Analytics Incorporated — Data Analysis Facilitation Suite (DAFS) (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoShenzhen Desida Technology Co., Ltd. — LED Light Therapy Mask (Models: T2, RLD10) (510k cleared)Fortior Technology (Shenzhen) Co., Ltd./ADR

    Product code: OHS. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 16, 2026device 510k153d agoShenzhen Ulike Smart Electronics Co., Ltd. — Ulike Reglow Light Therapy Device (UM10) (510k cleared)

    Product code: OHS. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Mar 16, 2026device pma153d agoIntera Oncology — MEDSTREAM PROGRAMMABLE INFUSION PUMP SYSTEM (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LKK. Advisory committee: HO. Decision: OK30

    full page →fda device pma ↗
    ›Mar 16, 2026device pma153d agoInspireMD, Ltd. — CGuard™ Prime Carotid Stent System (PMA supplement)InspireMD, Inc.

    Supplement type: 30-Day Notice. Product code: NIM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 16, 2026device pma153d agoOrganox Limited — OrganOx metra® System (PMA supplement)

    Supplement type: Real-Time Process. Product code: QQK. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 16, 2026grant153d agoH. LEE MOFFITT CANCER CTR & RES INST — A multimodal liquid biopsy assay to quantify androgen receptor’s somatic alte...

    CA grant. $225,511. PI: Manish Kohli

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Elucidating the role of a long noncoding RNA in Inflammatory Bowel Disease (IBD)

    DK grant. $587,470. PI: Sankar Ghosh

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoUNIVERSITY OF FLORIDA — Identification of approved drugs for BDNF insufficiencyUniversity of Florida

    NS grant. $423,750. PI: BAOJI XU

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoUNIVERSITY OF WASHINGTON — Serotonin and dopamine dynamics during kappa opioid mediated aversionUniversity of Washington

    DA grant. $46,988. PI: Micaela Vela Ruiz

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — An exosome-based liquid biopsy assay for the non-invasive early detection of ...City of Hope

    CA grant. $738,675. PI: Ajay Goel

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoJOHNS HOPKINS UNIVERSITY — CHARACTERIZING FLAGELLAR MOTILITY IN THE CONTEXT OF HOST-MICROBE SYMBIOSISJohns Hopkins University

    GM grant. $388,333. PI: Jonathan Lynch

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoCALIFORNIA INSTITUTE OF TECHNOLOGY — k-mer based local uniqueness exploration

    HG grant. $90,632. PI: Delaney Kalcey Sullivan

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Deciphering the genetic, functional, and therapeutic roles of TREM2 in diabet...

    DK grant. $656,180. PI: Jia Fu

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Mechanistic basis and therapeutic strategies for PPP2R1A mutation in gynecolo...

    CA grant. $653,967. PI: Rugang Zhang

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoUNIVERSITY OF MINNESOTA DULUTH — BRE-SPAD at the University of Minnesota DuluthUniversity of Minnesota

    GM grant. $759,572. PI: Erik T Brown

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoUNIVERSITY OF WASHINGTON — Developmental mechanisms underlying the functional diversification of facial ...University of Washington

    HD grant. $46,685. PI: Riku Yasutomi

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoGORDON RESEARCH CONFERENCES — 2026 Metals in Medicine Gordon Research Conference and Gordon Research Seminar

    CA grant. $5,000. PI: Maria Contel

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA — Recovery from Post-Stroke Aphasia With rTMS Targeting The Anterior Temporal L...

    DC grant. $146,004. PI: Sophie Arheix-Parras

    full page →nih reporter ↗
    ›Mar 16, 2026grant153d agoUNITED STATES ASSOCIATION FOR THE STUDY OF PAIN, INC. — US Association for the Study of Pain Annual Scientific Meeting

    AT grant. $60,000. PI: MICHAEL S GOLD

    full page →nih reporter ↗
    ›Mar 17, 2026approval152d agoALYFTREK (DEUTIVACAFTOR) — FDA approval(deutivacaftor + tezacaftor + vanzacaftor calcium)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →(deutivacaftor + tezacaftor + vanzacaftor calcium) →fda approvals ↗
    ›Mar 17, 2026approval152d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Mar 17, 2026approval152d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Mar 17, 2026approval152d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

    Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

    full page →(ivacaftor + lumacaftor) →fda approvals ↗
    ›Mar 17, 2026approval152d agoICOTYDE (ICOTROKINRA HYDROCHLORIDE) — FDA approvalicotrokinra hydrochloride

    Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

    full page →icotrokinra hydrochloride →fda approvals ↗
    ›Mar 17, 2026approval152d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

    Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 17, 2026approval152d agoAK-FLUOR 25% (FLUORESCEIN SODIUM) — FDA approvalLong Grove Pharmaceuticals LLC

    Sponsor: LONG GROVE PHARMS. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 17, 2026approval152d agoOXALIPLATIN — FDA approvalOXALIPLATIN

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →OXALIPLATIN →fda approvals ↗
    ›Mar 17, 2026approval152d agoOXALIPLATIN — FDA approvalOXALIPLATIN

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →OXALIPLATIN →fda approvals ↗
    ← prev
    page 13 of 149
    next →
    $PFE26.79-0.04%
    $VERX12.72-4.00%
    $VERX12.72-4.00%
    $VERX12.72-4.00%
    $VERX12.72-4.00%
    $FRTRY
    $NSPR0.7300+0.10%
    $VERX12.72-4.00%